Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schellong

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|March 23, 1999
Definition of a standard-risk group in children with AMLU Creutzig, M Zimmermann, J Ritter, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
Acute lymphoblastic leukemia: current status of therapy in childrenF Lampert, G Henze, H J Langermann, et al.
Onkologie|February 1, 1987
[High dosage ARA-C in combination with mitoxantrone in therapy of acute myeloid leukemia in childhood. Initial results of the AML BFM-85 recurrence study]J Ritter, U Creutzig, G Henze, et al.
Haematology and Blood Transfusion|January 1, 1987
The problem of early death in childhood AMLU Creutzig, K Stahnke, H Pollmann, et al.
Journal of Cancer Research and Clinical Oncology|July 27, 1979
Endodermal germ cell carcinoma (endodermal sinus tumor) of the vagina in infant girlsF K Beller, H Nienhaus, B S Gizycki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease GroupG Schellong, M Riepenhausen, U Creutzig, et al.
Klinische Padiatrie|December 17, 2003
Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studiesT Niehues, G Schellong, W Dörffel, et al.
Acta Paediatrica Scandinavica|March 1, 1989
The effect of the number of fractions of cranial irradiation on growth in children with acute lymphoblastic leukaemiaJ H Brämswig, M Wegele, H J von Lengerke, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1981
Thymic involvement and initial white blood count in childhood acute lymphoblastic leukemiaG Henze, H J Langermann, U Kaufmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study GroupG Schellong, J H Brämswig, I Hörnig-Franz, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|March 23, 1999
Definition of a standard-risk group in children with AMLU Creutzig, M Zimmermann, J Ritter, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
Acute lymphoblastic leukemia: current status of therapy in childrenF Lampert, G Henze, H J Langermann, et al.
Onkologie|February 1, 1987
[High dosage ARA-C in combination with mitoxantrone in therapy of acute myeloid leukemia in childhood. Initial results of the AML BFM-85 recurrence study]J Ritter, U Creutzig, G Henze, et al.
Haematology and Blood Transfusion|January 1, 1987
The problem of early death in childhood AMLU Creutzig, K Stahnke, H Pollmann, et al.
Journal of Cancer Research and Clinical Oncology|July 27, 1979
Endodermal germ cell carcinoma (endodermal sinus tumor) of the vagina in infant girlsF K Beller, H Nienhaus, B S Gizycki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease GroupG Schellong, M Riepenhausen, U Creutzig, et al.
Klinische Padiatrie|December 17, 2003
Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studiesT Niehues, G Schellong, W Dörffel, et al.
Acta Paediatrica Scandinavica|March 1, 1989
The effect of the number of fractions of cranial irradiation on growth in children with acute lymphoblastic leukaemiaJ H Brämswig, M Wegele, H J von Lengerke, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1981
Thymic involvement and initial white blood count in childhood acute lymphoblastic leukemiaG Henze, H J Langermann, U Kaufmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study GroupG Schellong, J H Brämswig, I Hörnig-Franz, et al.
Pageof 14